# Effect of TCI Propofol on Liver Transplant (TCI) Propofol on Intra-operative Usage of Vasopressors in Liver Transplant Recipients.

> **NCT06418893** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 60 (estimated)

## Conditions studied

- Liver Transplant Recipients

## Interventions

- **DRUG:** Target control infusion propofol
- **DRUG:** Inhalational isoflurane

## Key facts

- **NCT ID:** NCT06418893
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2024-10-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06418893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06418893, "Effect of TCI Propofol on Liver Transplant (TCI) Propofol on Intra-operative Usage of Vasopressors in Liver Transplant Recipients.". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06418893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*